Skip links

Clinical Trial Execution

End-to-end clinical research execution to support safe, compliant, and evidence-driven healthcare development across multiple therapeutic areas.

Clinical Trial Execution

Body Balance

End-to-end clinical research execution to support safe, compliant, and evidence-driven healthcare development across multiple therapeutic areas.

Validation Foundations

Human Trial Execution

Clinical trial execution transforms scientific discoveries into validated human outcomes. We support Phase I–III trials, medical device studies, investigator collaboration, and patient recruitment across Malaysia and Southeast Asia to accelerate clinical development.

Clinical Network • Management

A clinical execution process
– connecting investigator networks and patient recruitment
for validated outcomes.

Phase I–III Trials
Device
Research Network
Recruitment

End-to-end management of human clinical studies across multiple trial phases to evaluate safety, efficacy, and clinical performance under structured research protocols, supporting efficient execution and reliable clinical outcomes.

Phase I–III Human Trials

Clinical execution and validation for medical devices to support performance assessment, regulatory requirements, and evidence generation for real-world healthcare applications, ensuring safe and effective integration into clinical use.

Medical Device Clinical Studies

Collaboration with hospitals and clinical investigators across Malaysia and Southeast Asia to strengthen study execution, regional accessibility, and coordinated clinical operations across multiple research sites.

Hospital & Investigator Network

Structured recruitment and participant management processes designed to improve enrollment quality, operational efficiency, study readiness, and overall clinical trial performance and execution timelines.

Patient Recruitment Systems

What is Novabiotech Asia?
Novabiotech Asia is a Malaysia-based Contract Research Organization (CRO) providing integrated translational life sciences services including preclinical research, clinical trial execution, diagnostic laboratory testing, biomarker discovery, and translational healthcare validation across Southeast Asia.
Industry
Contract Research Organization (CRO)
Location
Malaysia / Southeast Asia
Core Services
Preclinical, Clinical Trials, Diagnostics
Focus
Clinical Healthcare Innovation & Validation
Novabiotech Asia is a Malaysia-based Contract Research Organization (CRO) specializing in translational life sciences, clinical trials, diagnostics, and preclinical research.
We provide preclinical research, clinical trial execution (Phase I–III), diagnostic laboratory services, biomarker discovery, and translational healthcare validation.
Our clients include pharmaceutical companies, biotechnology firms, medical device manufacturers, hospitals, universities, and research institutions.
We are based in Malaysia and serve clients across Southeast Asia including Singapore, Thailand, Indonesia, and Vietnam.

Scientific Confidence

Why It Matters

Accelerating Evidence. Delivering Outcomes.

Strong clinical execution improves study quality and research efficiency by ensuring reliable operations, validated data, and stronger readiness for real-world healthcare impact.

This website uses cookies to improve your web experience.